P1.01-02 Long-Term Outcomes with First-Line Nivolumab Plus...

Journal of Thoracic Oncology 2018 / 10 Vol. 13; Iss. 10

P1.01-02 Long-Term Outcomes with First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 3-Year Follow-Up from CheckMate 012

Antonia, S., Gettinger, S., Borghaei, H., Goldman, J.W., Brahmer, J., Ready, N., Gerber, D., Chow, L., Juergens, R., Laurie, S., Shepherd, F., Li, X., Li, A., Geese, W., Hellmann, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/J.JTHO.2018.08.558
Date:
October, 2018
File:
PDF, 185 KB
english, 2018
Conversion to is in progress
Conversion to is failed